C1QTNF3-AMACR
Description
The C1QTNF3-AMACR (C1QTNF3-AMACR readthrough (NMD candidate)) is a ncRNA gene located on chromosome 5.
C1QTNF3-AMACR, also known as prostate-specific membrane antigen (PSMA), is a type II transmembrane protein that is highly expressed in prostate cancer cells. It is a potential target for cancer therapy, and several PSMA-targeting drugs have been developed. The protein plays a role in cell adhesion, migration, and proliferation. It may also be involved in the regulation of prostate cancer cell growth and metastasis.
C1QTNF3-AMACR, also known as prostate-specific membrane antigen (PSMA), is a type II transmembrane protein that is highly expressed in prostate cancer cells. It is a potential target for cancer therapy, and several PSMA-targeting drugs have been developed. The protein plays a role in cell adhesion, migration, and proliferation. It may also be involved in the regulation of prostate cancer cell growth and metastasis.
C1QTNF3-AMACR is also known as -.
Associated Diseases
- isolated asymptomatic elevation of creatine phosphokinase
- plasma fibronectin deficiency
- osteoarthritis
- pentosuria
- chondrocalcinosis 2
- myopathy due to calsequestrin and SERCA1 protein overload
- metabolic myopathy due to lactate transporter defect
- glycoprotein storage disease
- isolated agammaglobulinemia
- Angel-shaped phalango-epiphyseal dysplasia
- talo-patello-scaphoid osteolysis
- immunodeficiency 25
- immunodeficiency, common variable, 14
- IgE responsiveness, atopic
- hyper-IgM syndrome type 5
- immunodeficiency, common variable, 4
- hyper-IgM syndrome type 3
- brachydactylous dwarfism, Mseleni type
